No Data
No Data
Harbin Gloria Pharmaceuticals (002437.SZ): The largest shareholder and acting in concert have collectively increased their shareholding by 1%.
On September 13, GeLongHui announced that Harbin Gloria Pharmaceuticals (002437.SZ) received a "Notice Letter" from Shen Zhenyu and Shanghai Fangyuan Capital Investment Partnership Enterprise (Limited Partnership) ("Shanghai Fangyuan"), and learned that from February 20, 2024 to September 13, 2024, Shanghai Fangyuan increased its shareholding in the company by 12.7751 million shares through the "Shanghai Fangyuan Capital Investment Partnership Enterprise (Limited Partnership) - Fangyuan-Oriental No. 6 Private Equity Investment Fund" ("Fangyuan No. 6 Fund") and the "Shanghai Fangyuan Capital Investment Partnership Enterprise (Limited Partnership) - Fangyuan-Oriental No. 12
Harbin Gloria Pharmaceuticals (002437.SZ) granted a total of 11.41 million restricted stocks to 45 incentive recipients.
Harbin Gloria Pharmaceuticals (002437.SZ) announced that the restrictions stipulated in the company's 2024 restricted stock incentive plan...
Harbin Gloria Pharmaceuticals: Half-year report for the year 2024.
Harbin Gloria Pharmaceuticals: Summary of Half-Year Report in 2024.
Chinese Securities Watchdog Warns Harbin Gloria Pharma Over Information Inaccuracies
As of August 9, 2024, Harbin Gloria Pharmaceuticals (002437.SZ) has a total of approximately 0.0985 million shareholders.
Harbin Gloria Pharmaceuticals (002437.SZ) stated on the investor communication platform on August 15th that as of August 9th, 2024, the total number of company shareholders was approximately 0.0985 million.
No Data
No Data